MedTrace Logo

A Combined Microdialysis and FDG-PET Study for Detection of Brain Injury After Cardiac Arrest

NCT04774055 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2022-04-20

No results posted yet for this study

Summary

Brain injury remains the leading cause of death in comatose patients resuscitated from OHCA. One of the most challenging aspects in the treatment of a post-cardiac arrest patient is the assessment of the extent of brain damage. Reliable, clinical measures of ongoing brain injury have potential to guide individualized treatment and potentially improve outcomes. Persistent candidate measures to fill this role is combined cerebral metabolism monitoring assessed by jugular bulb microdialysis (JBM) and positron emission tomography (PET) of 18-Fluor deoxyglucose (\[F-18\]-FDG). This multimodal neuromonitoring is cutting-edge technology used in a clinical setting

Conditions

  • Cardiac Arrest
  • Brain Injuries

Sponsors & Collaborators

  • Odense University Hospital

    lead OTHER

Principal Investigators

  • Simon Mølstrøm, MD · Odense University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-25
Primary Completion
2023-03-01
Completion
2023-12-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04774055 on ClinicalTrials.gov